Connect with us

EU

Investment Plan for Europe backs fund to support health-care innovation

SHARE:

Published

6 years ago

on

We use your sign-up to provide content in ways you've consented to and to improve our understanding of you. You can unsubscribe at any time.

The European Investment Fund (EIF) has committed €30 million to the BGV Fund IV by BioGeneration Ventures (BGV), a venture capital company supporting early-stage European biotech companies in health care. The EIF's commitment is made possible through a guarantee provided by the European Fund for Strategic Investments (EFSI), the main pillar of the Investment Plan for Europe. The BGV Fund IV, which has closed at €140m, has already made four investments with a focus on entrepreneurial therapeutic innovation, with more to come. Economy Commissioner Paolo Gentiloni said: “I warmly welcome the Investment Plan for Europe's support for this EIF investment in BGV. It will support this specialised fund to finance early-stage European biotech companies operating at the forefront of health-care innovation.” The Investment Plan for Europe has so far mobilized €535 billion of investment across the EU, a quarter of which for research, development and innovation projects. The press release is available here.

Share this article:

Share this:
Related Topics:
EU Reporter publishes articles from a variety of outside sources which express a wide range of viewpoints. The positions taken in these articles are not necessarily those of EU Reporter. Please see EU Reporter’s full Terms and Conditions of publication for more information EU Reporter embraces artificial intelligence as a tool to enhance journalistic quality, efficiency, and accessibility, while maintaining strict human editorial oversight, ethical standards, and transparency in all AI-assisted content. Please see EU Reporter’s full A.I. Policy for more information.
Advertisement

Trending